Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Recent Advances in Pulmonary Hypertension
Author(s): Akshyaya Pradhan , Richa Tyagi , Prachi Sharma , et al Added: 1 year ago

Prevention & Chronic Conditions
30th Annual Meeting of the ISCP
Author(s): Daryl Dakay , Marion Patricio Added: 1 month ago

Prevention & Chronic Conditions

Heart Failure
Viewpoint on Arterial Hypertension
Author(s): Maria Lorenza Muiesan Added: 1 year ago

Prevention & Chronic Conditions
Arterial Hypertension: Highlights from the European Society of Cardiology 2025 Congress
Author(s): Maria Lorenza Muiesan , Matteo Lemoli Added: 6 months ago

Prevention & Chronic Conditions
Research Area(s) / Expertise: Job title: Director of the National Pulmonary Hypertension Service
Shao-Liang Chen
Dr Shao-Liang Chen is an interventional cardiologist at theNanjing First Hospital, Nanjing Medical University, Jiangsu Province, Nanjing, China. Dr Chen has published over 300 papers in peer-reviewed journals. Dr Chen's research interests include coronary intervention, pulmonary arterial hypertension and biological molecular science. Dr Shao-Liang Chen is Section Editor of European… View more
Research Area(s) / Expertise: Job title: Head of the Paediatric Cardiology Unit
Job title: Assistant Professor of Medicine in the Division of Cardiology and Director of the Pulmonary Vascular Diseases Program
Myung H Park, MD, FACC, is an Assistant Professor of Medicine in the Division of Cardiology and Director of the Pulmonary Vascular Diseases Program at the University of Maryland School of Medicine. She is a member of the American College of Cardiology, the Heart Failure Society of America, the International Society of Heart and Lung Transplantation, and the Pulmonary Hypertension Association… View more
Shih-Hsien Sung
Research Area(s) / Expertise: Job title: Professor
Dr Adam Sung (Dr Shih-Hsien Sung) received his MD and PhD degrees fromNational Yang-Ming University, Taiwan,in 2001 and 2014, respectively. He has been on the faculty of National Yang Ming Chiao Tung University since 2019, where he is currently a professor. He completed internal medicine residency training and cardiology fellowship training at Taipei Veterans General Hospital in 2009, where he is… View more
ACC 25 Late-Breaking Discussion: The ADVANCE-HTN Trial
Author(s): Harriette Van Spall , Luke Laffin Added: 1 year ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial… View more

Prevention & Chronic Conditions